Nagaro T, Shimizu C, Inoue H, Fujitani T, Adachi N, Amakawa K, Kimura S, Arai T, Watanabe T, Oka S
Department of Anesthesiology & Resuscitology, Ehime University School of Medicine.
Masui. 1995 Jun;44(6):862-7.
We examined the efficacy of systemic local anesthetics on various types of neuropathic pain in 89 patients. Lidocaine 1.5 mg.kg-1 was infused intravenously for one minute. Pain score (PS) by visual analogue scale (VAS, 0-10) was measured 1, 5, 15 and 35 min after the infusion. The efficacy of intravenous lidocaine was evaluated by PS which was lowest after infusion. PS decreased to less than 50 percent of pre-infusion value in more than 75 percent of cases of cancer pain, postherpetic neuralgia, trigeminal neuralgia, low back pain with signs of root pain or spinal canal stenosis, peripheral nerve injury and thalamic pain, in 50-75 percent of cases of herpetic neuralgia, and in less than 50 percent of cases of cervical spondylosis, spinal cord injury, reflex sympathetic dystrophy, causalgia and psychogenic pain. This study suggests that systemic local anesthetics is effective in neuropathy due to cancer pain, postherpetic neuralgia, trigeminal neuralgia, low back pain with signs of root pain or spinal canal stenosis, peripheral nerve injury and thalamic pain.
我们研究了全身局部麻醉药对89例各种类型神经病理性疼痛的疗效。静脉注射1.5mg.kg-1利多卡因1分钟。在注射后1、5、15和35分钟,通过视觉模拟量表(VAS,0-10)测量疼痛评分(PS)。静脉注射利多卡因的疗效通过注射后最低的PS来评估。在超过75%的癌症疼痛、带状疱疹后神经痛、三叉神经痛、伴有神经根疼痛或椎管狭窄体征的腰痛、周围神经损伤和丘脑痛病例中,PS降至注射前值的50%以下;在50%-75%的疱疹性神经痛病例中,PS降至注射前值的50%以下;在不到50%的颈椎病、脊髓损伤、反射性交感神经营养不良、灼性神经痛和心因性疼痛病例中,PS降至注射前值的50%以下。本研究表明,全身局部麻醉药对癌症疼痛、带状疱疹后神经痛、三叉神经痛、伴有神经根疼痛或椎管狭窄体征的腰痛、周围神经损伤和丘脑痛引起的神经病变有效。